WebDec 7, 2024 · Brisbane-based Ellume, which collapsed owing about $140 million in August, has been snapped up by privately owned Hough Consolidated Pty Ltd, which owns Hough Rapid. It is understood Ellume’s administrator signed the deal on Wednesday morning, and it remains subject to approval from the group’s creditors. WebSep 1, 2024 · It was apparently a big blow for the company which had been touting itself for sale through an ASX listing and IPO earlier this year. ... Ellume issued a short statement today which said the Directors of the Australian business Ellume Limited had today appointed John Park and Joanne Dunn of FTI Consulting as Voluntary Administrators, …
Ellume’s big biotech IPO still on the table - Australian Financial …
WebMar 9, 2024 · Ellume’s big biotech IPO still on the table. Yolanda Redrup, Sarah Thompson and Kanika Sood. Mar 9, 2024 – 9.35pm. There’s at least one $600 million-plus biotech still testing the IPO waters ... WebJun 24, 2024 · In partnership with AZOVA, now available Ellume COVID-19 Home Tests … snafu bmx seat
Ellume plucked out of administration via $57m sale
Web医疗技术初创公司SpeeDx是最新一家获得安德鲁·福雷斯特(Andrew Forrest)的Tenmile健康科技基金支持的公司，该基金获得2600万美元的投资，试图开发可以告诉医生如何治疗感染的技术。SpeeDx最初是2009年从医疗巨头强生公司(Johnson & Johnson)的一个诊断开发项目中剥离出来的，但总部设在澳大利亚，现在在19个 ... WebDec 21, 2024 · 21 December 2024 Photo: Ellume, via Facebook. Creditors of Brisbane-based infectious disease testing products developer Ellume have agreed to a US$38 million ($57 million) deal that will see the business, known for its rapid COVID-19 test, enter the hands of competitor Hough Consolidated. WebAug 25, 2024 · Ellume secures US$30M from National Institutes of Health (NIH) RADx initiative to accelerate development of rapid COVID-19 diagnostics. Core fluorescent immunoassay platform will create three high-performance COVID-19 antigen tests for at-home, point-of-care and high-throughput diagnostic settings. Ellume’s at-home test … rmv massachusetts vanity plate search